Φορτώνει......
Azacitidine in outpatient treatment – single center experience
AIM OF THE STUDY: Azacitidine is a hypomethylating agent which is used in the treatment of myelodysplastic syndromes, acute myeloid leukemia and chronic myelomonocytic leukemia. Because of good tolerance to the drug, azacitidine can be administered both during hospitalization and in an outpatient se...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Contemp Oncol (Pozn) |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Termedia Publishing House
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4731453/ https://ncbi.nlm.nih.gov/pubmed/26843844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2015.56653 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|